In a new report being presented at CHEST 2018, researchers investigated whether patients with acute decompensated heart failure can be safely managed in the Medical Intermediate Care unit vs the general...
Low levels of LDL cholesterol reduce the risk of cardiovascular disease and events. However, is it safe to reduce LDL cholesterol levels that are already low? A new study investigates.
A new study aimed to determine whether 6 non-invasive cardiac tests could reclassify patients into a post-test probability that defines or excludes anatomically and functionally significant CAD.
Our Cardiometabolic Risk Summit 2018 wrapped up this Sunday with a plethora of educational sessions. Couldn’t make the trip? Catch up with our news coverage!
In light of the current hypertension epidemic, Florian Rader, MD, advised about distinguishing resistant hypertension from mimics and described the latest treatment options, as well as those on the...
James A. Underberg, MD, outlined recent cardiovascular outcomes evidence for PCSK9 inhibitors and discussed strategies for improving access to therapy for appropriate patients.
In his session at CRS 2018, Dr Edward Shahady discussed the importance of early recognition of diabetes, outlining appropriate prevention and treatment measures for the numerous micro- and macrovascular...
Hypertension guidelines recommend limits for systolic and diastolic blood pressure. But regardless of whether systolic BP is controlled, diastolic BP can still affect cardiovascular outcomes.
